HCA Healthcare

HCA · NYSE · USD

$426.69Change from previous close: +0.78%Absolute change: +$3.30

Close · October 2, 2026

At a glance

Revenue growth
+7.08%
2025 vs 2024
Net income growth
+17.78%
2025 vs 2024
Net margin
9.0%
2024: 8.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue75,60070,60364,96860,233—
Cost of revenue44,22641,92539,38937,056—
Gross profit31,37428,67825,57923,177—
Selling, general and administrative—31,17029,48727,68526,779
Operating income11,96510,5479,6279,053—
EBIT12,08010,5849,64410,321—
EBITDA15,60313,89612,72113,290—
Interest expense2,2482,0611,9381,741—
Pre-tax income9,8328,5237,7068,580—
Income tax2,0501,8661,6151,746—
Net income6,7845,7605,2425,643—
Net income to common shareholders6,7845,7605,2425,643—
Basic EPS30.2023.0419.7419.43—
Diluted EPS28.3322.0018.9719.15—
Average shares (basic)225250266290—
Average shares (diluted)239262276295—